Compare DRTS & CSWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | CSWC |
|---|---|---|
| Founded | 2015 | 1961 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2021 | 1994 |
| Metric | DRTS | CSWC |
|---|---|---|
| Price | $13.34 | $23.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $17.80 | ★ $25.08 |
| AVG Volume (30 Days) | ★ 471.5K | 452.2K |
| Earning Date | 11-19-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 10.76% |
| EPS Growth | N/A | ★ 29.25 |
| EPS | N/A | ★ 0.73 |
| Revenue | N/A | ★ $10,835,000.00 |
| Revenue This Year | N/A | $17.73 |
| Revenue Next Year | $1,235.59 | $14.87 |
| P/E Ratio | ★ N/A | $32.59 |
| Revenue Growth | N/A | ★ 16.08 |
| 52 Week Low | $3.43 | $20.11 |
| 52 Week High | $15.79 | $25.75 |
| Indicator | DRTS | CSWC |
|---|---|---|
| Relative Strength Index (RSI) | 54.48 | 59.93 |
| Support Level | $13.73 | $22.96 |
| Resistance Level | $15.23 | $23.87 |
| Average True Range (ATR) | 0.66 | 0.41 |
| MACD | 0.10 | 0.14 |
| Stochastic Oscillator | 92.31 | 94.02 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source of revenue comprises interest income and dividend income from investments made as well as management fees.